Acer therapeutics reports q4 and full year 2022 financial results and provides corporate update

Newton, mass., march 27, 2023 (globe newswire) -- acer therapeutics inc. (nasdaq: acer), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious, rare and life-threatening diseases with significant unmet medical needs, today reported financial results for q4 and full year ended december 31, 2022, and provided an update on the company's recent corporate developments.
ACER Ratings Summary
ACER Quant Ranking